Gracell Biotechnologies Inc ADR
(GRCL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,518 | N/A | -70,892 | N/A | N/A |
| Depreciation Amortization | 5,055 | N/A | 7,041 | N/A | N/A |
| Other Working Capital | 5,700 | N/A | 3,963 | N/A | N/A |
| Other Operating Activity | 4,201 | 0 | 12,096 | 0 | 0 |
| Operating Cash Flow | $-30,562 | $N/A | $-47,792 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -25,169 | N/A | 2,374 | N/A | N/A |
| PPE Investments | -3,672 | N/A | -8,904 | N/A | N/A |
| Investing Cash Flow | $-28,841 | $N/A | $-6,530 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 7,405 | N/A | 11,178 | N/A | N/A |
| Common Stock Issued | 20 | N/A | 274 | N/A | N/A |
| Other Financing Activity | -2,676 | 0 | 217,055 | 0 | 0 |
| Financing Cash Flow | $4,749 | $N/A | $228,507 | $N/A | $N/A |
| Exchange Rate Effect | 10,778 | N/A | -5,541 | N/A | N/A |
| Beginning Cash Position | 273,063 | N/A | 118,367 | N/A | N/A |
| End Cash Position | 229,187 | N/A | 287,011 | N/A | N/A |
| Net Cash Flow | $-43,876 | $N/A | $168,644 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,562 | N/A | -47,792 | N/A | N/A |
| Capital Expenditure | -3,672 | N/A | -8,904 | N/A | N/A |
| Free Cash Flow | -34,234 | 0 | -56,696 | 0 | 0 |